^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    TMB-H + HER-2 positive

    i
    Other names: TMB | Tumor Mutational Burden, ERBB2, CD340, HER-2, HER2, NEU, NGL, V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2
    Entrez ID:
    2064
    Related biomarkers:
    Expression
    Mutation
    CNA
    Fusion
    Others
    2years
    Exceptional Response to Pembrolizumab and Trastuzumab in a Heavily Pretreated Patient With HER2-Positive TMB-H and MSI-H Metastatic Breast Cancer. (PubMed, JCO Precis Oncol)
    No abstract available
    Clinical • Journal
    |
    HER-2 (Human epidermal growth factor receptor 2) • TMB (Tumor Mutational Burden) • MSI (Microsatellite instability)
    |
    HER-2 positive • TMB-H • MSI-H/dMMR • TMB-H + HER-2 positive
    |
    Keytruda (pembrolizumab) • Herceptin (trastuzumab)